Caribou Biosciences, Inc. (CRBU)
0.4699
+0.01
(+1.12%)
USD |
NASDAQ |
Oct 16, 16:00
0.4671
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Net Income (TTM) : -103.40M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -103.40M |
| March 31, 2026 | -133.22M |
| December 31, 2025 | -148.12M |
| September 30, 2025 | -157.13M |
| June 30, 2025 | -164.26M |
| March 31, 2025 | -147.86M |
| December 31, 2024 | -149.10M |
| September 30, 2024 | -148.12M |
| June 30, 2024 | -123.44M |
| March 31, 2024 | -115.26M |
| December 31, 2023 | -102.07M |
| September 30, 2023 | -94.55M |
| Date | Value |
|---|---|
| June 30, 2023 | -111.20M |
| March 31, 2023 | -108.38M |
| December 31, 2022 | -99.42M |
| September 30, 2022 | -90.91M |
| June 30, 2022 | -85.24M |
| March 31, 2022 | -72.85M |
| December 31, 2021 | -66.92M |
| September 30, 2021 | -63.15M |
| June 30, 2021 | -50.11M |
| March 31, 2021 | -37.67M |
| December 31, 2020 | -34.31M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Intellia Therapeutics, Inc. | -399.98M |
| Vir Biotechnology, Inc. | -251.68M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |
| Sangamo Therapeutics, Inc. | -123.33M |